Syneos Health (FRA:8IN) Additional Paid-In Capital : €3,232 Mil(As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Syneos Health Additional Paid-In Capital?

Syneos Health's quarterly additional paid-in capital declined from Dec. 2022 (€3,266 Mil) to Mar. 2023 (€3,253 Mil) but then stayed the same from Mar. 2023 (€3,253 Mil) to Jun. 2023 (€3,232 Mil).

Syneos Health's annual additional paid-in capital increased from Dec. 2020 (€2,846 Mil) to Dec. 2021 (€3,075 Mil) and increased from Dec. 2021 (€3,075 Mil) to Dec. 2022 (€3,266 Mil).

Syneos Health Additional Paid-In Capital Historical Data

The historical data trend for Syneos Health's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneos Health Additional Paid-In Capital Chart

Syneos Health Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

2,990.92

3,097.32

2,845.56

3,074.57

3,266.38

Syneos Health Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial															3,240.60	3,483.89	3,266.38	3,252.76	3,232.35

Syneos Health Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Syneos Health Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Syneos Health's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Syneos Health (FRA:8IN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (FRA:8IN) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

1030 Sync Street, Morrisville, NC, USA, 27560-5468

Website

https://www.syneoshealth.com

Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Syneos Health (FRA:8IN) Headlines

No Headlines